Please note: AABB reserves the right to make updates to this program.
Wednesday, September 26, 2018
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 18EL-364 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Director, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Resident/Fellow, Technologists, Transfusion Safety Officer
Teaching Level: Intermediate to Advanced
Director/Moderator: NurJehan Quraishy, MD, Assistant Medical Director, Transfusion Medicine, Cleveland Clinic, Cleveland, OH
Speakers: Priscilla I. Figueroa, MD, Section Head Transfusion Medicine, Medical Director Transfusion Medicine and Stem Cell Laboratory, Cleveland Clinic, Cleveland, OH; Celeste Dean-El, MS, SBB(ASCP)cm, Supervisor Immunohematology, Cleveland Clinic, Cleveland, OH
After participating in this educational activity, participants should be able to:
- Discuss key advantageous of implementing automated blood bank analyzers relative to manual testing.
- List some of the pitfalls of automation and their potential impact on workload.
- Evaluate whether a tubeless transfusion service is feasible for your institution.
Qualified specialized blood bank technologists are a difficult to find resource for large transfusion services, and a luxury for many laboratories. Automation in Blood Banking helps sustain high quality blood bank services through built-in process controls including highly reliable sample identification, electronic result entry, mandatory quality control, reagent tracking, standardized reaction grading, rapid turn-around-time, and the potential for increased productivity by freeing testing personal to perform other critical functions. However, highly sensitive test systems also have disadvantages that may generate unintended consequences. This program will discuss the advantages and disadvantages of automation, and address the impact and feasibility of a “tubeless” blood bank.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Dr. Figueroa is Section Head of Transfusion Medicine at the Cleveland Clinic, Cleveland, OH. Her special interests include blood banking, transfusion medicine, stem cell and quality management. She received her bachelor’s degree from Harvard University and her MD from Cornell University Medical College in New York City. She completed her TM fellowship at the Mayo Clinic.
Celeste Dean-El is the Immunohematology Supervisor at the Cleveland Clinic. She has worked as a blood bank technologist at the Cleveland Clinic since 2006 performing complex antibody workups. She also has experience in Quality Management in both Transfusion Services and Anatomic Pathology. She is certified as a Specialist in Blood Bank with a Master of Science in Clinical Laboratory Management.